[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing",
    "summary": "Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=e917a8e83a152e7bdfc518fcc2ad2a1f05bd1ef60d9fb0358f88f9b89f835f8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758923103,
      "headline": "Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing",
      "id": 136896966,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=e917a8e83a152e7bdfc518fcc2ad2a1f05bd1ef60d9fb0358f88f9b89f835f8e"
    }
  },
  {
    "ts": null,
    "headline": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?",
    "summary": "ABBV eyes a 2025 rebound as Skyrizi and Rinvoq drive growth beyond Humira, with oncology and neuroscience adding momentum.",
    "url": "https://finnhub.io/api/news?id=f94823b0b710280a05310f850e35629c0191f2798fbdc1ec587b9d079aefbf90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758901500,
      "headline": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?",
      "id": 136896933,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ABBV eyes a 2025 rebound as Skyrizi and Rinvoq drive growth beyond Humira, with oncology and neuroscience adding momentum.",
      "url": "https://finnhub.io/api/news?id=f94823b0b710280a05310f850e35629c0191f2798fbdc1ec587b9d079aefbf90"
    }
  },
  {
    "ts": null,
    "headline": "Trump's new tariffs on pharma, furniture, & trucks: What to know",
    "summary": "President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White House columnist for The Hill, Niall Stanage, and Yahoo Finance senior reporter Brooke DiPalma outline the details of the tariff policy and examine the respective market reactions. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=d7991ae95fc41cdc2d33538ff9b6e84b21dd938423a6bbf5b5aea179b58efa25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758895101,
      "headline": "Trump's new tariffs on pharma, furniture, & trucks: What to know",
      "id": 136892599,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White House columnist for The Hill, Niall Stanage, and Yahoo Finance senior reporter Brooke DiPalma outline the details of the tariff policy and examine the respective market reactions. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=d7991ae95fc41cdc2d33538ff9b6e84b21dd938423a6bbf5b5aea179b58efa25"
    }
  },
  {
    "ts": null,
    "headline": "Big pharma stocks rise as Street reacts to latest presidential tariff plan",
    "summary": "Shares of some big drugmakers jumped ahead of broader indexes Friday as Wall Street started sorting out President Donald Trump’s latest tariff announcement.  The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply to companies building U.S. manufacturing plants.  Several big drugmakers like Merck & Co. Inc., Eli Lilly and Co. and Johnson & Johnson have announced U.S. expansion plans.",
    "url": "https://finnhub.io/api/news?id=4b37a7be94a8687633bc24664a4565f06a7e6f2105839c6b4d6ce3ced85e7422",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758892447,
      "headline": "Big pharma stocks rise as Street reacts to latest presidential tariff plan",
      "id": 136892606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Shares of some big drugmakers jumped ahead of broader indexes Friday as Wall Street started sorting out President Donald Trump’s latest tariff announcement.  The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply to companies building U.S. manufacturing plants.  Several big drugmakers like Merck & Co. Inc., Eli Lilly and Co. and Johnson & Johnson have announced U.S. expansion plans.",
      "url": "https://finnhub.io/api/news?id=4b37a7be94a8687633bc24664a4565f06a7e6f2105839c6b4d6ce3ced85e7422"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues",
    "summary": "We recently published 14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in unborn children. The firm’s shares have lost 22% […]",
    "url": "https://finnhub.io/api/news?id=b26b4083724726f5a45ef84db7e39ee1d22ad69f63ba5ebbf3cb6fdfe734ad13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758891308,
      "headline": "Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues",
      "id": 136892654,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published 14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in unborn children. The firm’s shares have lost 22% […]",
      "url": "https://finnhub.io/api/news?id=b26b4083724726f5a45ef84db7e39ee1d22ad69f63ba5ebbf3cb6fdfe734ad13"
    }
  },
  {
    "ts": null,
    "headline": "What to Expect From Johnson & Johnson’s Q3 2025 Earnings Report",
    "summary": "Johnson & Johnson is expected to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings rise.",
    "url": "https://finnhub.io/api/news?id=b7c37e3cd66419aa87ba4ce535b1b54168bc734638e1b37b0d685c8216f64bbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758888681,
      "headline": "What to Expect From Johnson & Johnson’s Q3 2025 Earnings Report",
      "id": 136892655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson is expected to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings rise.",
      "url": "https://finnhub.io/api/news?id=b7c37e3cd66419aa87ba4ce535b1b54168bc734638e1b37b0d685c8216f64bbf"
    }
  },
  {
    "ts": null,
    "headline": "President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio",
    "summary": "Explore how Trump's MFN pricing and 100% drug import tariffs impact pharma stocks.",
    "url": "https://finnhub.io/api/news?id=f87454e5d95e6da200bbd80a0968fd7d3fa1631bf2ee86d435f94ffa5e918741",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758885865,
      "headline": "President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio",
      "id": 136892883,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1645808639/image_1645808639.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Explore how Trump's MFN pricing and 100% drug import tariffs impact pharma stocks.",
      "url": "https://finnhub.io/api/news?id=f87454e5d95e6da200bbd80a0968fd7d3fa1631bf2ee86d435f94ffa5e918741"
    }
  },
  {
    "ts": null,
    "headline": "Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?",
    "summary": "There is a lot to like about this healthcare company, but that goal might be beyond its powers.",
    "url": "https://finnhub.io/api/news?id=ec71b9500a3e71ce39acc73dfc15ff55e73dd2aa50f13302d67383688df88139",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758885660,
      "headline": "Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?",
      "id": 136892656,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "There is a lot to like about this healthcare company, but that goal might be beyond its powers.",
      "url": "https://finnhub.io/api/news?id=ec71b9500a3e71ce39acc73dfc15ff55e73dd2aa50f13302d67383688df88139"
    }
  },
  {
    "ts": null,
    "headline": "Boeing, IBM share gains lead Dow's nearly 150-point jump",
    "summary": "Boeing, IBM share gains lead Dow's nearly 150-point jump",
    "url": "https://finnhub.io/api/news?id=4a45e27902cffd8ce0aa14169197adaa4fe5d85f2d0822accdd44b525f9f5c2f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758883560,
      "headline": "Boeing, IBM share gains lead Dow's nearly 150-point jump",
      "id": 136921267,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Boeing, IBM share gains lead Dow's nearly 150-point jump",
      "url": "https://finnhub.io/api/news?id=4a45e27902cffd8ce0aa14169197adaa4fe5d85f2d0822accdd44b525f9f5c2f"
    }
  },
  {
    "ts": null,
    "headline": "The Stock Market Is Up, but the Dollar Is Down. What It Means for You.",
    "summary": "The Stock Market Is Up, but the Dollar Is Down. What It Means for You.",
    "url": "https://finnhub.io/api/news?id=3be1dc1cbe7531fdd37233a5694523152954d7f4cc264bb814a87787cec6e24e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758881340,
      "headline": "The Stock Market Is Up, but the Dollar Is Down. What It Means for You.",
      "id": 136921043,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "The Stock Market Is Up, but the Dollar Is Down. What It Means for You.",
      "url": "https://finnhub.io/api/news?id=3be1dc1cbe7531fdd37233a5694523152954d7f4cc264bb814a87787cec6e24e"
    }
  },
  {
    "ts": null,
    "headline": "J&J: Still a Defensive Giant, or Too Dependent on Pharma?",
    "summary": "J&J is posting good growth and is available at fair valuations.",
    "url": "https://finnhub.io/api/news?id=582411f3925bcecda41bbfb7369487e682b0926bdd884ec74fd2cea379754ea6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758877577,
      "headline": "J&J: Still a Defensive Giant, or Too Dependent on Pharma?",
      "id": 136892657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J is posting good growth and is available at fair valuations.",
      "url": "https://finnhub.io/api/news?id=582411f3925bcecda41bbfb7369487e682b0926bdd884ec74fd2cea379754ea6"
    }
  },
  {
    "ts": null,
    "headline": "Is pharma’s IRA pricing battle running out of steam?",
    "summary": "Despite recent court losses, the legal tides could still turn in the industry’s favor.",
    "url": "https://finnhub.io/api/news?id=f6aa2163f1c3fff410027754855b17bdfd6b031ab8367e07eb13b66d6ab1b6d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758876102,
      "headline": "Is pharma’s IRA pricing battle running out of steam?",
      "id": 136892658,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Despite recent court losses, the legal tides could still turn in the industry’s favor.",
      "url": "https://finnhub.io/api/news?id=f6aa2163f1c3fff410027754855b17bdfd6b031ab8367e07eb13b66d6ab1b6d5"
    }
  },
  {
    "ts": null,
    "headline": "Trump Plans New Tariff Push With 100% Rate on Patented Drugs",
    "summary": "“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump posted on social media Thursday, without offering specifics on which producers will be impacted.  “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”",
    "url": "https://finnhub.io/api/news?id=405bb7558df757d18271ae19363d916f178b5c7324db98af9d47ec112ffd5d4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758871035,
      "headline": "Trump Plans New Tariff Push With 100% Rate on Patented Drugs",
      "id": 136890601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump posted on social media Thursday, without offering specifics on which producers will be impacted.  “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”",
      "url": "https://finnhub.io/api/news?id=405bb7558df757d18271ae19363d916f178b5c7324db98af9d47ec112ffd5d4e"
    }
  }
]